List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 52 studies with search of: "Hyperphosphatemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Another Phosphate binder
2 Active, not recruiting Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Intervention: Drug: MCI-196
3 Completed A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo;   Drug: Another phosphate binder
4 Recruiting Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia
Conditions: Hyperphosphatemia;   Chronic Kidney Disease
Interventions: Other: FOSTRAP Chewing Gum;   Other: Placebo chewing gum
5 Completed A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo
6 Active, not recruiting Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Conditions: Chronic Kidney Disease;   Renal Dialysis;   Renal Insufficiency;   Hyperphosphatemia
Intervention: Drug: APS1585
7 Recruiting A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo
8 Completed A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
Conditions: Hyperphosphatemia;   Chronic Kidney Disease
Interventions: Drug: ASP1585;   Drug: Placebo;   Drug: Sevelamer hydrochloride
9 Completed A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia;   Dyslipidemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Placebo
10 Recruiting A Study of HS219 in Chronic Kidney Disease Patient on Hemodialysis With Hyperphosphatemia
Conditions: Hyperphosphatemia;   Chronic Kidney Disease
Interventions: Dietary Supplement: HS219;   Dietary Supplement: Placebo
11 Terminated Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Hyperphosphatemia;   Renal Osteodystrophy
Intervention:
12 Completed Long-Term Treatment on Bay 77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone
Conditions: Hyperphosphatemia;   Dialysis
Intervention: Drug: Lanthanum Carbonate (BAY77-1931)
13 Completed BAY 77-1931 Long-Term Extension From Phase II Study
Condition: Hyperphosphatemia
Intervention: Drug: BAY 77-1931
14 Not yet recruiting Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
Conditions: Haemodialyzed Patients;   Hyperphosphatemia
Interventions: Drug: Calcium acetate;   Drug: Sevelamer
15 Completed The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
Condition: Hyperphosphatemia
Intervention: Drug: Niacinamide
16 Recruiting Bioequivalence Study of BAY77-1931 Granule
Condition: Hyperphosphatemia
Interventions: Drug: Lanthanum Carbonate (Fosrenol, BAY77-1931) Granule;   Drug: Lanthanum Carbonate (Fosrenol, BAY77-1931) Chewable tablet
17 Completed The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
Condition: Hyperphosphatemia
Interventions: Drug: Niacinamide;   Drug: Placebo
18 Recruiting Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Conditions: Hyperphosphatemia;   End-Stage Renal Disease;   Hemodialysis;   di;   Dialysis
Intervention: Drug: ferric citrate
19 Active, not recruiting Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
Conditions: Kidney Diseases;   Renal Insufficiency
Intervention: Drug: ILY101
20 Recruiting Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis
Condition: Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
Interventions: Drug: SBR759;   Drug: Sevelamer HCl

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services